Kraig Biocraft Laboratories (KBLB) Operating Income (2010 - 2026)

Kraig Biocraft Laboratories has disclosed Operating Income across 16 years of filings, most recently posting -$703433.0 for Q2 2026.

• In Q2 2026, Operating Income fell 10.3% year-over-year to -$703433.0; the TTM figure through Jun 2026 stood at -$3.5 million (down 48.34% YoY), while the FY2025 annual figure was -$3.4 million, down 9.77% from the prior year.
• Operating Income came in at -$703433.0 for Q2 2026 at Kraig Biocraft Laboratories, up from -$722668.0 in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$423797.0 in Q3 2024 to a low of -$1.5 million in Q2 2024.
• Average Operating Income over 5 years is -$699348.5, with a median of -$545711.0 recorded in 2022.
• The largest YoY upside for Operating Income was 57.09% in 2025 against a maximum downside of 238.34% in 2025.
• Over 5 years, Operating Income stood at -$513685.0 in 2022, then plunged by 131.29% to -$1.2 million in 2023, then jumped by 39.74% to -$715916.0 in 2024, then retreated by 0.94% to -$722668.0 in 2025, then gained by 2.66% to -$703433.0 in 2026.
• Per Business Quant data, the three most recent Operating Income figures were -$703433.0 in Q2 2026, -$722668.0 in Q4 2025, and -$1.4 million in Q3 2025.